vs

Side-by-side financial comparison of DSS, INC. (DSS) and Scilex Holding Co (SCLX). Click either name above to swap in a different company.

Scilex Holding Co is the larger business by last-quarter revenue ($4.8M vs $4.1M, roughly 1.2× DSS, INC.). DSS, INC. runs the higher net margin — -420.6% vs -961.9%, a 541.3% gap on every dollar of revenue. On growth, DSS, INC. posted the faster year-over-year revenue change (-23.8% vs -67.8%). Over the past eight quarters, DSS, INC.'s revenue compounded faster (3.2% CAGR vs -33.6%).

DSS, Inc. is a diversified technology company offering product authentication solutions, secure identification services, blockchain-based innovation, digital asset management tools, and healthcare technology products. It primarily serves North American, Asian, and European markets across consumer goods, financial services, and healthcare core segments.

Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.

DSS vs SCLX — Head-to-Head

Bigger by revenue
SCLX
SCLX
1.2× larger
SCLX
$4.8M
$4.1M
DSS
Growing faster (revenue YoY)
DSS
DSS
+44.0% gap
DSS
-23.8%
-67.8%
SCLX
Higher net margin
DSS
DSS
541.3% more per $
DSS
-420.6%
-961.9%
SCLX
Faster 2-yr revenue CAGR
DSS
DSS
Annualised
DSS
3.2%
-33.6%
SCLX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DSS
DSS
SCLX
SCLX
Revenue
$4.1M
$4.8M
Net Profit
$-17.4M
$-46.1M
Gross Margin
45.5%
Operating Margin
-98.1%
-2317.8%
Net Margin
-420.6%
-961.9%
Revenue YoY
-23.8%
-67.8%
Net Profit YoY
47.2%
-613.7%
EPS (diluted)
$-4.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DSS
DSS
SCLX
SCLX
Q4 25
$4.1M
$4.8M
Q3 25
$6.4M
$10.6M
Q2 25
$5.3M
$9.9M
Q1 25
$5.0M
$5.0M
Q4 24
$5.4M
$14.9M
Q3 24
$5.6M
$14.4M
Q2 24
$4.2M
$16.4M
Q1 24
$3.9M
$10.9M
Net Profit
DSS
DSS
SCLX
SCLX
Q4 25
$-17.4M
$-46.1M
Q3 25
$-2.2M
$-257.8M
Q2 25
$-2.6M
$-44.0M
Q1 25
$-5.3M
$-26.1M
Q4 24
$-32.9M
$-6.5M
Q3 24
$-5.3M
$-4.4M
Q2 24
$-4.7M
$-37.6M
Q1 24
$-4.1M
$-24.4M
Gross Margin
DSS
DSS
SCLX
SCLX
Q4 25
45.5%
Q3 25
68.5%
Q2 25
66.9%
Q1 25
72.3%
Q4 24
68.5%
Q3 24
73.9%
Q2 24
73.2%
Q1 24
64.7%
Operating Margin
DSS
DSS
SCLX
SCLX
Q4 25
-98.1%
-2317.8%
Q3 25
-50.6%
-1766.2%
Q2 25
-64.8%
-207.2%
Q1 25
-75.2%
-557.5%
Q4 24
-522.7%
-190.5%
Q3 24
-83.4%
-138.0%
Q2 24
-117.2%
-95.4%
Q1 24
-120.9%
-179.0%
Net Margin
DSS
DSS
SCLX
SCLX
Q4 25
-420.6%
-961.9%
Q3 25
-34.9%
-2441.5%
Q2 25
-49.3%
-445.1%
Q1 25
-106.9%
-521.2%
Q4 24
-606.7%
-43.4%
Q3 24
-94.4%
-30.4%
Q2 24
-111.2%
-229.6%
Q1 24
-105.2%
-224.0%
EPS (diluted)
DSS
DSS
SCLX
SCLX
Q4 25
$-4.63
Q3 25
$-22.17
Q2 25
$-7.42
Q1 25
$-2.26
Q4 24
$-4.64
$8.53
Q3 24
$-0.75
$-0.58
Q2 24
$-0.66
$-7.67
Q1 24
$-0.58
$-8.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DSS
DSS
SCLX
SCLX
Cash + ST InvestmentsLiquidity on hand
$8.9M
$5.0M
Total DebtLower is stronger
$44.7M
Stockholders' EquityBook value
$-832.0K
$-207.8M
Total Assets
$67.6M
$365.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DSS
DSS
SCLX
SCLX
Q4 25
$8.9M
$5.0M
Q3 25
$8.7M
$878.0K
Q2 25
$12.4M
$4.1M
Q1 25
$17.3M
$5.8M
Q4 24
$14.3M
$3.3M
Q3 24
$18.9M
$77.0K
Q2 24
$20.3M
$6.9M
Q1 24
$17.7M
$1.8M
Total Debt
DSS
DSS
SCLX
SCLX
Q4 25
$44.7M
Q3 25
$50.2M
Q2 25
$43.9M
Q1 25
$49.3M
Q4 24
$57.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DSS
DSS
SCLX
SCLX
Q4 25
$-832.0K
$-207.8M
Q3 25
$14.2M
$-176.9M
Q2 25
$15.7M
$-249.0M
Q1 25
$17.9M
$-211.5M
Q4 24
$19.9M
$-192.6M
Q3 24
$52.1M
$-211.3M
Q2 24
$55.2M
$-214.7M
Q1 24
$59.9M
$-189.8M
Total Assets
DSS
DSS
SCLX
SCLX
Q4 25
$67.6M
$365.0M
Q3 25
$92.1M
$275.9M
Q2 25
$93.4M
$83.8M
Q1 25
$92.4M
$79.0M
Q4 24
$106.5M
$93.0M
Q3 24
$142.7M
$100.4M
Q2 24
$144.4M
$104.5M
Q1 24
$148.5M
$91.2M
Debt / Equity
DSS
DSS
SCLX
SCLX
Q4 25
Q3 25
3.54×
Q2 25
2.80×
Q1 25
2.76×
Q4 24
2.87×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DSS
DSS
SCLX
SCLX
Operating Cash FlowLast quarter
$-1.6M
$-17.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DSS
DSS
SCLX
SCLX
Q4 25
$-1.6M
$-17.5M
Q3 25
$-8.0M
$8.2M
Q2 25
$2.1M
$7.0M
Q1 25
$-1.6M
$6.0M
Q4 24
$-2.9M
$2.5M
Q3 24
$-315.0K
$5.1M
Q2 24
$-3.4M
$2.3M
Q1 24
$-2.1M
$9.4M
Free Cash Flow
DSS
DSS
SCLX
SCLX
Q4 25
Q3 25
$-8.1M
Q2 25
$2.0M
Q1 25
$-1.7M
Q4 24
$-3.0M
Q3 24
Q2 24
$-3.5M
Q1 24
$-2.2M
FCF Margin
DSS
DSS
SCLX
SCLX
Q4 25
Q3 25
-126.5%
Q2 25
37.4%
Q1 25
-34.1%
Q4 24
-54.9%
Q3 24
Q2 24
-81.9%
Q1 24
-55.6%
Capex Intensity
DSS
DSS
SCLX
SCLX
Q4 25
Q3 25
1.3%
Q2 25
1.7%
Q1 25
1.0%
Q4 24
1.9%
Q3 24
0.0%
0.0%
Q2 24
0.6%
Q1 24
0.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons